Bitwise’s XRP ETF nears launch as the firm files its final SEC amendment, confirming an NYSE listing and 0.34% management fee amid surging institutional interest.
Shares fall flat; Origin’s revenue drops; Mayne Pharma shares decline as investors bet on its takeover deal being dead; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback